[
  {
    "title": "康弘药业(002773.SZ)：拟将基因治疗业务整合至弘基生物、将生物合成业务整合至弘合生物",
    "href": "http://stock.jrj.com.cn/2022/12/30075437248314.shtml",
    "datetime": "2022-12-30 07:54:36",
    "code": "002773"
  },
  {
    "title": "康弘药业(002773.SZ)：草酸艾司西酞普兰口服溶液获批上市",
    "href": "http://stock.jrj.com.cn/2022/12/22192837232253.shtml",
    "datetime": "2022-12-22 19:28:43",
    "code": "002773"
  },
  {
    "title": "康弘药业：控股股东、实际控制人柯潇拟增持不超过700万股",
    "href": "http://stock.jrj.com.cn/2022/12/02175537185052.shtml",
    "datetime": "2022-12-02 17:55:40",
    "code": "002773"
  },
  {
    "title": "康弘药业(002773.SZ)：控股股东拟增持不超700万股",
    "href": "http://stock.jrj.com.cn/2022/12/02175437185098.shtml",
    "datetime": "2022-12-02 17:54:20",
    "code": "002773"
  },
  {
    "title": "康弘药业(002773.SZ)：子公司KH631眼用注射液在美获批临床试验",
    "href": "http://stock.jrj.com.cn/2022/11/23170037161019.shtml",
    "datetime": "2022-11-23 17:00:07",
    "code": "002773"
  },
  {
    "title": "康弘药业(002773.SZ)：酒石酸匹莫范色林胶囊获准开展临床试验",
    "href": "http://stock.jrj.com.cn/2022/11/15183937141094.shtml",
    "datetime": "2022-11-15 18:39:01",
    "code": "002773"
  },
  {
    "title": "康弘药业(002773.SZ)：KH631眼用注射液获准开展临床试验",
    "href": "http://stock.jrj.com.cn/2022/11/15183637141099.shtml",
    "datetime": "2022-11-15 18:36:24",
    "code": "002773"
  },
  {
    "title": "康弘药业(002773.SZ)第三季度净利2.18亿元 同比下降6.46%",
    "href": "http://stock.jrj.com.cn/2022/10/28014237092131.shtml",
    "datetime": "2022-10-28 01:42:51",
    "code": "002773"
  },
  {
    "title": "康弘药业：子公司获得药品临床试验批准",
    "href": "http://stock.jrj.com.cn/2022/09/22192637015025.shtml",
    "datetime": "2022-09-22 19:26:30",
    "code": "002773"
  },
  {
    "title": "康弘药业(002773.SZ)：弘合生物的注射用KH617获批临床试验",
    "href": "http://stock.jrj.com.cn/2022/09/22192537015036.shtml",
    "datetime": "2022-09-22 19:25:49",
    "code": "002773"
  },
  {
    "title": "康弘药业(002773.SZ)：舒肝解郁胶囊获批国家中药二级保护品种",
    "href": "http://stock.jrj.com.cn/2022/09/13114436990683.shtml",
    "datetime": "2022-09-13 11:44:46",
    "code": "002773"
  },
  {
    "title": "康弘药业(002773.SZ)：KH631眼用注射液临床试验申请获受理",
    "href": "http://stock.jrj.com.cn/2022/08/30201736954299.shtml",
    "datetime": "2022-08-30 20:17:52",
    "code": "002773"
  },
  {
    "title": "康弘药业(002773.SZ)半年度净利润5.37亿元 同比增长27.73%",
    "href": "http://stock.jrj.com.cn/2022/08/22190836922608.shtml",
    "datetime": "2022-08-22 19:08:42",
    "code": "002773"
  },
  {
    "title": "康弘药业(002773.SZ)：弘基生物撤回KH631眼用注射液临床试验申请",
    "href": "http://stock.jrj.com.cn/2022/08/08174336879596.shtml",
    "datetime": "2022-08-08 17:43:59",
    "code": "002773"
  },
  {
    "title": "康弘药业(002773.SZ)：KH617获美FDA新药临床试验许可",
    "href": "http://stock.jrj.com.cn/2022/07/29173336854345.shtml",
    "datetime": "2022-07-29 17:33:27",
    "code": "002773"
  },
  {
    "title": "康弘药业(002773.SZ)：阿立哌唑口崩片参与全国药品集中采购拟中标",
    "href": "http://stock.jrj.com.cn/2022/07/13175336808029.shtml",
    "datetime": "2022-07-13 17:53:06",
    "code": "002773"
  },
  {
    "title": "康弘药业(002773.SZ)：子公司药品临床试验申请获得受理",
    "href": "http://stock.jrj.com.cn/2022/07/10171236797034.shtml",
    "datetime": "2022-07-10 17:12:54",
    "code": "002773"
  },
  {
    "title": "康弘药业(002773.SZ)：拟推2022年股票增值权激励计划",
    "href": "http://stock.jrj.com.cn/2022/06/30205536772952.shtml",
    "datetime": "2022-06-30 20:55:32",
    "code": "002773"
  },
  {
    "title": "康弘药业(002773.SZ)：四川弘远完成吸收合并四川弘达",
    "href": "http://stock.jrj.com.cn/2022/06/24115436756056.shtml",
    "datetime": "2022-06-24 11:54:51",
    "code": "002773"
  },
  {
    "title": "康弘药业：收到药物临床试验批准通知书",
    "href": "http://stock.jrj.com.cn/2022/06/16142436734353.shtml",
    "datetime": "2022-06-16 14:24:09",
    "code": "002773"
  },
  {
    "title": "康弘药业(002773.SZ)：治疗成人精神分裂症药物盐酸卡利拉嗪胶囊获同意开展临床试验",
    "href": "http://stock.jrj.com.cn/2022/06/16124136734043.shtml",
    "datetime": "2022-06-16 12:41:03",
    "code": "002773"
  },
  {
    "title": "康弘药业(002773.SZ)：2021年度权益分派10派1元 股权登记日为6月7日",
    "href": "http://stock.jrj.com.cn/2022/05/30180236690332.shtml",
    "datetime": "2022-05-30 18:02:23",
    "code": "002773"
  },
  {
    "title": "康弘药业(002773.SZ)：康柏西普眼用注射液获批新增预充式注射器包装",
    "href": "http://stock.jrj.com.cn/2022/05/27172936685065.shtml",
    "datetime": "2022-05-27 17:29:20",
    "code": "002773"
  },
  {
    "title": "康弘药业(002773.SZ)：康柏西普眼用注射液第四个适应症获批",
    "href": "http://stock.jrj.com.cn/2022/05/09114936604096.shtml",
    "datetime": "2022-05-09 11:49:38",
    "code": "002773"
  },
  {
    "title": "康弘药业(002773.SZ)：子公司KH631临床试验申请获受理",
    "href": "http://stock.jrj.com.cn/2022/05/06200536582659.shtml",
    "datetime": "2022-05-06 20:05:46",
    "code": "002773"
  },
  {
    "title": "子公司计提商誉减值2.1亿 康弘药业扭亏后能否延续增长",
    "href": "http://stock.jrj.com.cn/2022/05/05082036566584.shtml",
    "datetime": "2022-05-05 08:20:00",
    "code": "002773"
  },
  {
    "title": "康弘药业(002773.SZ)：2021年净利扭亏为盈至4.21亿元 拟10派1元",
    "href": "http://stock.jrj.com.cn/2022/04/30003636509086.shtml",
    "datetime": "2022-04-30 00:36:59",
    "code": "002773"
  },
  {
    "title": "康弘药业(002773.SZ)：一季度净利润增27.22%至2.97亿元",
    "href": "http://stock.jrj.com.cn/2022/04/30003436509087.shtml",
    "datetime": "2022-04-30 00:34:01",
    "code": "002773"
  },
  {
    "title": "康弘药业(002773.SZ)：奥贝胆酸片获批开展临床试验",
    "href": "http://stock.jrj.com.cn/2022/04/24193236449040.shtml",
    "datetime": "2022-04-24 19:32:26",
    "code": "002773"
  },
  {
    "title": "康弘药业(002773.SZ)：盐酸文拉法辛缓释片收到再注册批准通知书",
    "href": "http://stock.jrj.com.cn/2022/04/21114936417144.shtml",
    "datetime": "2022-04-21 11:49:32",
    "code": "002773"
  },
  {
    "title": "康弘药业(002773.SZ)：子公司收到康柏西普眼用注射液药品补充申请批准通知书",
    "href": "http://stock.jrj.com.cn/2022/02/07115334298991.shtml",
    "datetime": "2022-02-07 11:53:50",
    "code": "002773"
  },
  {
    "title": "康弘药业2021年预计净利4亿-5.2亿同比扭亏为盈 主营业务稳定增长",
    "href": "http://stock.jrj.com.cn/2022/01/26215134225822.shtml",
    "datetime": "2022-01-26 21:51:51",
    "code": "002773"
  },
  {
    "title": "康弘药业(002773.SZ)：2021年度预盈4亿元-5.2亿元 同比扭亏",
    "href": "http://stock.jrj.com.cn/2022/01/26185634224540.shtml",
    "datetime": "2022-01-26 18:56:31",
    "code": "002773"
  },
  {
    "title": "康弘药业：两家子公司使用合计1.1亿元自有资金购买银行理财产品",
    "href": "http://stock.jrj.com.cn/2022/01/26145734223218.shtml",
    "datetime": "2022-01-26 14:57:29",
    "code": "002773"
  },
  {
    "title": "康弘药业(002773.SZ)：拟使用不超20亿元自有资金购买理财产品",
    "href": "http://stock.jrj.com.cn/2022/01/13193634155249.shtml",
    "datetime": "2022-01-13 19:36:28",
    "code": "002773"
  },
  {
    "title": "康弘药业(002773.SZ)：康柏西普眼用注射液被纳入国家医保目录",
    "href": "http://stock.jrj.com.cn/2021/12/03192233961249.shtml",
    "datetime": "2021-12-03 19:22:28",
    "code": "002773"
  },
  {
    "title": "康弘药业：康柏西普眼用注射液被纳入国家医保目录",
    "href": "http://stock.jrj.com.cn/2021/12/03191833961233.shtml",
    "datetime": "2021-12-03 19:18:28",
    "code": "002773"
  },
  {
    "title": "康弘药业(002773.SZ)：董事、副总裁陈粟辞职",
    "href": "http://stock.jrj.com.cn/2021/11/15194133855763.shtml",
    "datetime": "2021-11-15 19:41:15",
    "code": "002773"
  },
  {
    "title": "康弘药业(002773.SZ)：增持期届满 控股股东柯潇已累计增持500万股",
    "href": "http://stock.jrj.com.cn/2021/11/15193833855751.shtml",
    "datetime": "2021-11-15 19:38:46",
    "code": "002773"
  },
  {
    "title": "康弘药业(002773.SZ)：增持期届满 副总裁殷劲群累计增持10.12万股",
    "href": "http://stock.jrj.com.cn/2021/11/09183133828474.shtml",
    "datetime": "2021-11-09 18:31:08",
    "code": "002773"
  },
  {
    "title": "康弘药业(002773.SZ)：氢溴酸伏硫西汀片获得药品注册证书",
    "href": "http://stock.jrj.com.cn/2021/11/09182833828464.shtml",
    "datetime": "2021-11-09 18:28:04",
    "code": "002773"
  },
  {
    "title": "康弘药业前三季营利齐增，实现营收28.45亿元",
    "href": "http://stock.jrj.com.cn/2021/10/28175333770440.shtml",
    "datetime": "2021-10-28 17:53:36",
    "code": "002773"
  },
  {
    "title": "康弘药业KH737滴眼液获批开展临床试验",
    "href": "http://stock.jrj.com.cn/2021/10/19193833717796.shtml",
    "datetime": "2021-10-19 19:38:46",
    "code": "002773"
  },
  {
    "title": "康弘药业：KH737滴眼液获批开展临床试验",
    "href": "http://stock.jrj.com.cn/2021/10/19180733717438.shtml",
    "datetime": "2021-10-19 18:07:10",
    "code": "002773"
  },
  {
    "title": "康弘药业(002773.SZ)：KH737滴眼液获批开展临床试验",
    "href": "http://stock.jrj.com.cn/2021/10/19180333717409.shtml",
    "datetime": "2021-10-19 18:03:08",
    "code": "002773"
  },
  {
    "title": "业绩与股价“分离” 高管增持仍难提振市场对康弘药业的信心",
    "href": "http://stock.jrj.com.cn/2021/09/07110233397775.shtml",
    "datetime": "2021-09-07 11:02:00",
    "code": "002773"
  },
  {
    "title": "康弘药业股东钟建军增持50.06万股 耗资1373.15万 上半年公司净利4.2亿",
    "href": "http://stock.jrj.com.cn/2021/09/06202433394302.shtml",
    "datetime": "2021-09-06 20:24:46",
    "code": "002773"
  },
  {
    "title": "康弘药业(002773.SZ)：获得盐酸普拉克索缓释片的药品注册证书",
    "href": "http://stock.jrj.com.cn/2021/09/06172333392696.shtml",
    "datetime": "2021-09-06 17:23:54",
    "code": "002773"
  },
  {
    "title": "康弘药业：副总裁增持计划已实施完毕 累计增持1.02%公司股份",
    "href": "http://stock.jrj.com.cn/2021/09/06141233391927.shtml",
    "datetime": "2021-09-06 14:12:45",
    "code": "002773"
  },
  {
    "title": "康弘药业(002773.SZ)：高管钟建军完成增持50.06万股",
    "href": "http://stock.jrj.com.cn/2021/09/06123633391518.shtml",
    "datetime": "2021-09-06 12:36:32",
    "code": "002773"
  },
  {
    "title": "康弘药业：公司及子公司使用自有资金2亿元购买理财产品",
    "href": "http://stock.jrj.com.cn/2021/09/02142133374036.shtml",
    "datetime": "2021-09-02 14:21:59",
    "code": "002773"
  },
  {
    "title": "康弘药业营收净利双增股价背道而驰",
    "href": "http://stock.jrj.com.cn/2021/08/31082333358505.shtml",
    "datetime": "2021-08-31 08:23:36",
    "code": "002773"
  },
  {
    "title": "康弘药业2021年半年度净利4.2亿元 同比净利增加25.68%",
    "href": "http://stock.jrj.com.cn/2021/08/29194033341300.shtml",
    "datetime": "2021-08-29 19:40:55",
    "code": "002773"
  },
  {
    "title": "康弘药业(002773.SZ)半年度净利润4.20亿元 同比增长25.68%",
    "href": "http://stock.jrj.com.cn/2021/08/29172633340782.shtml",
    "datetime": "2021-08-29 17:26:17",
    "code": "002773"
  },
  {
    "title": "康弘药业股东钟建军增持25.06万股 耗资915.69万 一季度公司净利2.34亿",
    "href": "http://stock.jrj.com.cn/2021/08/06220133214868.shtml",
    "datetime": "2021-08-06 22:01:05",
    "code": "002773"
  },
  {
    "title": "康弘药业(002773.SZ)：财务总监钟建军已累计增持25.06万股",
    "href": "http://stock.jrj.com.cn/2021/08/06182433213794.shtml",
    "datetime": "2021-08-06 18:24:09",
    "code": "002773"
  },
  {
    "title": "康弘药业(002773.SZ)：向410名激励对象授予1207万份股票期权",
    "href": "http://stock.jrj.com.cn/2021/07/15212433103693.shtml",
    "datetime": "2021-07-15 21:24:16",
    "code": "002773"
  },
  {
    "title": "康弘药业(002773.SZ)：拟与员工持股平台共设四川弘合生物 开展生物合成技术和产品的相关业务",
    "href": "http://stock.jrj.com.cn/2021/07/15212333103690.shtml",
    "datetime": "2021-07-15 21:23:04",
    "code": "002773"
  },
  {
    "title": "康弘药业(002773.SZ)：为开展基因疗法开发业务 拟引入员工持股平台对弘基生物增资",
    "href": "http://stock.jrj.com.cn/2021/07/15212033103675.shtml",
    "datetime": "2021-07-15 21:20:47",
    "code": "002773"
  },
  {
    "title": "康弘药业(002773.SZ)：盐酸文拉法辛缓释片(75mg)拟中标第五批全国药品集采",
    "href": "http://stock.jrj.com.cn/2021/06/24201532991397.shtml",
    "datetime": "2021-06-24 20:15:33",
    "code": "002773"
  },
  {
    "title": "康弘药业：公司治疗糖尿病的KH805处于临床前研究阶段",
    "href": "http://stock.jrj.com.cn/2021/06/24143732989364.shtml",
    "datetime": "2021-06-24 14:37:54",
    "code": "002773"
  },
  {
    "title": "康弘药业：公司对PANDA试验的分析和调查仍在进行中",
    "href": "http://stock.jrj.com.cn/2021/06/22115532975496.shtml",
    "datetime": "2021-06-22 11:55:03",
    "code": "002773"
  },
  {
    "title": "康弘药业：公司目前上市药物中暂无控制和治疗近视的用药",
    "href": "http://stock.jrj.com.cn/2021/06/22115332975487.shtml",
    "datetime": "2021-06-22 11:53:38",
    "code": "002773"
  },
  {
    "title": "康弘药业(002773.SZ)拟推1600万份的2021年股票期权激励计划",
    "href": "http://stock.jrj.com.cn/2021/06/20203532961724.shtml",
    "datetime": "2021-06-20 20:35:08",
    "code": "002773"
  },
  {
    "title": "康弘药业(002773.SZ)筹划推出股权激励计划",
    "href": "http://stock.jrj.com.cn/2021/06/15120932933619.shtml",
    "datetime": "2021-06-15 12:09:54",
    "code": "002773"
  },
  {
    "title": "康弘药业：子公司济生堂药业使用自有资金7000万元购买理财产品",
    "href": "http://stock.jrj.com.cn/2021/06/09141832899509.shtml",
    "datetime": "2021-06-09 14:18:57",
    "code": "002773"
  },
  {
    "title": "康弘药业： KH805、KH806都处于临床前研究阶段 目前进展顺利",
    "href": "http://stock.jrj.com.cn/2021/06/09095932898123.shtml",
    "datetime": "2021-06-09 09:59:05",
    "code": "002773"
  },
  {
    "title": "康弘药业(002773.SZ)：阿立哌唑口服溶液扩展适应症人群获批",
    "href": "http://stock.jrj.com.cn/2021/06/07183632887819.shtml",
    "datetime": "2021-06-07 18:36:01",
    "code": "002773"
  },
  {
    "title": "康弘药业：康弘生物康柏西普眼用注射液收到《药物临床试验批准通知书》",
    "href": "http://stock.jrj.com.cn/2021/06/04133832873684.shtml",
    "datetime": "2021-06-04 13:38:08",
    "code": "002773"
  },
  {
    "title": "康弘药业(002773.SZ)：董事、副总裁殷劲群增持量过半 累计增持10.12万股",
    "href": "http://stock.jrj.com.cn/2021/06/04121632873438.shtml",
    "datetime": "2021-06-04 12:16:33",
    "code": "002773"
  },
  {
    "title": "康弘药业(002773.SZ)：康柏西普眼用注射液新增适应症获批临床",
    "href": "http://stock.jrj.com.cn/2021/06/04120032873393.shtml",
    "datetime": "2021-06-04 12:00:47",
    "code": "002773"
  },
  {
    "title": "康弘药业(002773.SZ)2020年度权益分派10派1元 股权登记日为6月10日",
    "href": "http://stock.jrj.com.cn/2021/06/02171332863881.shtml",
    "datetime": "2021-06-02 17:13:30",
    "code": "002773"
  },
  {
    "title": "康弘药业：2020年度权益分派实施 每10股派发现金红利1.0元（含税）",
    "href": "http://stock.jrj.com.cn/2021/06/02170932864170.shtml",
    "datetime": "2021-06-02 17:09:13",
    "code": "002773"
  },
  {
    "title": "康弘药业：子公司四川康贸使用自有资金2.7亿元购买理财产品",
    "href": "http://stock.jrj.com.cn/2021/05/31144532849941.shtml",
    "datetime": "2021-05-31 14:45:42",
    "code": "002773"
  },
  {
    "title": "康弘药业：目前公司正在重新考虑北京工厂未来的相关规划",
    "href": "http://stock.jrj.com.cn/2021/05/31131032848595.shtml",
    "datetime": "2021-05-31 13:10:33",
    "code": "002773"
  },
  {
    "title": "【龙虎榜】康弘药业5月27日成交明细",
    "href": "http://stock.jrj.com.cn/hotstock/2021/05/27180132830904.shtml",
    "datetime": "2021-05-27 18:01:13",
    "code": "002773"
  },
  {
    "title": "康弘药业(002773)：控股股东暨实际控制人股份增持计划的进展",
    "href": "http://stock.jrj.com.cn/2021/05/20183732788837.shtml",
    "datetime": "2021-05-20 18:37:50",
    "code": "002773"
  },
  {
    "title": "康弘药业(002773.SZ)：实控人柯潇已增持500万股",
    "href": "http://stock.jrj.com.cn/2021/05/20180932788067.shtml",
    "datetime": "2021-05-20 18:09:00",
    "code": "002773"
  },
  {
    "title": "康弘药业(002773.SZ)：董事、副总裁殷劲群拟增持不超20万股",
    "href": "http://stock.jrj.com.cn/2021/05/05175832677329.shtml",
    "datetime": "2021-05-05 17:58:21",
    "code": "002773"
  },
  {
    "title": "康弘药业：目前公司在销的仿制药不存在知识产权诉讼风险",
    "href": "http://stock.jrj.com.cn/2021/04/29122732479237.shtml",
    "datetime": "2021-04-29 12:27:16",
    "code": "002773"
  },
  {
    "title": "康弘药业：业绩“爆雷”引发连锁反应",
    "href": "http://stock.jrj.com.cn/2021/04/29073732477404.shtml",
    "datetime": "2021-04-29 07:37:29",
    "code": "002773"
  },
  {
    "title": "康弘药业预盈8.4亿突变亏2.7亿，高毅冯柳现持1330万股",
    "href": "http://stock.jrj.com.cn/2021/04/28155132471743.shtml",
    "datetime": "2021-04-28 15:51:50",
    "code": "002773"
  },
  {
    "title": "临床试验14亿打水漂，康弘药业预盈8.4亿突变亏2.7亿，牵连34亿定增被撤回",
    "href": "http://stock.jrj.com.cn/2021/04/28112132470074.shtml",
    "datetime": "2021-04-28 11:21:35",
    "code": "002773"
  },
  {
    "title": "A股异动丨康弘药业(002773.SZ)涨停 一季度营收、净利双双创下历史同期新高",
    "href": "http://stock.jrj.com.cn/2021/04/28110032469888.shtml",
    "datetime": "2021-04-28 11:00:25",
    "code": "002773"
  },
  {
    "title": "A股异动丨康弘药业(002773.SZ)年内跌幅达60% 大幅下修业绩快报 机构纷纷出逃",
    "href": "http://stock.jrj.com.cn/2021/04/27105532460704.shtml",
    "datetime": "2021-04-27 10:55:12",
    "code": "002773"
  },
  {
    "title": "业绩前后差11亿 公募私募甩卖康弘药业",
    "href": "http://stock.jrj.com.cn/2021/04/27072832459607.shtml",
    "datetime": "2021-04-27 07:28:30",
    "code": "002773"
  },
  {
    "title": "康弘药业去年净利降138% 首季兴全董承非季文华等减持",
    "href": "http://stock.jrj.com.cn/2021/04/26164432454619.shtml",
    "datetime": "2021-04-26 16:44:00",
    "code": "002773"
  },
  {
    "title": "药物临床试验被停！康弘药业业绩从预盈8.4亿到预亏2.7亿",
    "href": "http://stock.jrj.com.cn/2021/04/26094732452030.shtml",
    "datetime": "2021-04-26 09:47:37",
    "code": "002773"
  },
  {
    "title": "这只医药股“炸雷”，预盈8亿到预亏近3亿！一个多月股价腰斩",
    "href": "http://stock.jrj.com.cn/2021/04/26080132451393.shtml",
    "datetime": "2021-04-26 08:01:35",
    "code": "002773"
  },
  {
    "title": "海外临床试验“爆雷”！这只医药股炸了，预盈8亿到预亏近3亿！13亿研发费打水漂，一个多月股价直接腰斩",
    "href": "http://stock.jrj.com.cn/2021/04/26073732451290.shtml",
    "datetime": "2021-04-26 07:37:40",
    "code": "002773"
  },
  {
    "title": "康弘药业(002773.SZ)大幅下修业绩快报：2020年度净亏损2.7亿元",
    "href": "http://stock.jrj.com.cn/2021/04/25225932440313.shtml",
    "datetime": "2021-04-25 22:59:56",
    "code": "002773"
  },
  {
    "title": "康弘药业(002773.SZ)：立他司特滴眼液获准开展临床试验",
    "href": "http://stock.jrj.com.cn/2021/04/23132832429581.shtml",
    "datetime": "2021-04-23 13:28:37",
    "code": "002773"
  },
  {
    "title": "康弘药业：“康柏西普眼用注射液国际Ⅲ期临床试验及注册上市项目”已无法继续实施",
    "href": "http://stock.jrj.com.cn/2021/04/22140632422735.shtml",
    "datetime": "2021-04-22 14:06:51",
    "code": "002773"
  },
  {
    "title": "康弘药业：全球公共卫生事件对本研究的影响大大超过公司的预期",
    "href": "http://stock.jrj.com.cn/2021/04/21194832418252.shtml",
    "datetime": "2021-04-21 19:48:49",
    "code": "002773"
  },
  {
    "title": "康弘药业4天重挫33% 刘彦春、董承非等基金经理或“踩雷”",
    "href": "http://stock.jrj.com.cn/2021/04/15184732380982.shtml",
    "datetime": "2021-04-15 18:47:29",
    "code": "002773"
  },
  {
    "title": "康弘药业3跌停后还跌 兴全两大佬董承非谢治宇或持股",
    "href": "http://stock.jrj.com.cn/2021/04/15171132380296.shtml",
    "datetime": "2021-04-15 17:11:00",
    "code": "002773"
  },
  {
    "title": "康弘药业：部分创新药产品进展良好，实控人增持彰显信心",
    "href": "http://stock.jrj.com.cn/2021/04/15162332380281.shtml",
    "datetime": "2021-04-15 16:23:55",
    "code": "002773"
  },
  {
    "title": "康弘药业出海爆雷连续3日一字跌停!景顺长城刘彦春等基金经理“踩雷”",
    "href": "http://stock.jrj.com.cn/2021/04/15092332377350.shtml",
    "datetime": "2021-04-15 09:23:07",
    "code": "002773"
  },
  {
    "title": "叫停核心产品临床试验 康弘药业三跌停",
    "href": "http://stock.jrj.com.cn/2021/04/15071532376567.shtml",
    "datetime": "2021-04-15 07:15:32",
    "code": "002773"
  },
  {
    "title": "【龙虎榜】康弘药业4月14日成交明细",
    "href": "http://stock.jrj.com.cn/hotstock/2021/04/14180132372729.shtml",
    "datetime": "2021-04-14 18:01:01",
    "code": "002773"
  },
  {
    "title": "停止全球PANDA试验 康弘药业(002773.SZ)连续3日一字跌停",
    "href": "http://stock.jrj.com.cn/2021/04/14102932369900.shtml",
    "datetime": "2021-04-14 10:29:17",
    "code": "002773"
  },
  {
    "title": "康弘药业(002773.SZ)：实控人柯潇拟增持不超1000万股",
    "href": "http://stock.jrj.com.cn/2021/04/13213032367078.shtml",
    "datetime": "2021-04-13 21:30:48",
    "code": "002773"
  },
  {
    "title": "康弘药业：康柏西普在国内获批的三个适应症的临床数据已经报送至国家药监部门",
    "href": "http://stock.jrj.com.cn/2021/04/13151932364794.shtml",
    "datetime": "2021-04-13 15:19:18",
    "code": "002773"
  },
  {
    "title": "康弘药业：PANDA试验科学指导委员会是公司聘请的由国内外顶级眼底病专家组成的一个委员会",
    "href": "http://stock.jrj.com.cn/2021/04/13143632364532.shtml",
    "datetime": "2021-04-13 14:36:10",
    "code": "002773"
  },
  {
    "title": "康弘药业：未来三年 公司预计每年都将会有1类原创的新产品进入临床试验阶段",
    "href": "http://stock.jrj.com.cn/2021/04/13140032364347.shtml",
    "datetime": "2021-04-13 14:00:49",
    "code": "002773"
  },
  {
    "title": "康弘药业：公司在包括小分子新药研发、合成生物、基因治疗、抗体开发等多个方面的研究已初见成效",
    "href": "http://stock.jrj.com.cn/2021/04/13135732364290.shtml",
    "datetime": "2021-04-13 13:57:29",
    "code": "002773"
  },
  {
    "title": "康弘药业：公司于2021年4月9日线上举办了“康柏西普全球多中心临床试验停止情况说明会”",
    "href": "http://stock.jrj.com.cn/2021/04/13134732364254.shtml",
    "datetime": "2021-04-13 13:47:53",
    "code": "002773"
  },
  {
    "title": "康弘药业：康柏西普国际3期临床试验已经累计投入131111.49万元",
    "href": "http://stock.jrj.com.cn/2021/04/13134732364255.shtml",
    "datetime": "2021-04-13 13:47:37",
    "code": "002773"
  },
  {
    "title": "康弘药业：康柏西普的临床应用就会重回正轨",
    "href": "http://stock.jrj.com.cn/2021/04/13101532363195.shtml",
    "datetime": "2021-04-13 10:15:56",
    "code": "002773"
  },
  {
    "title": "康弘药业：公司对PANDA试验的分析和调查仍在进行中",
    "href": "http://stock.jrj.com.cn/2021/04/13101432363193.shtml",
    "datetime": "2021-04-13 10:14:29",
    "code": "002773"
  },
  {
    "title": "康弘药业：公司经过慎重研究 尊重PANDA科学指导委员会的专业评估及建议 停止全球PANDA试验",
    "href": "http://stock.jrj.com.cn/2021/04/13095932363067.shtml",
    "datetime": "2021-04-13 09:59:35",
    "code": "002773"
  },
  {
    "title": "康弘药业：康柏西普2019 年获批用于治疗糖尿病黄斑水肿（DME）引起的视力损害",
    "href": "http://stock.jrj.com.cn/2021/04/13095632363039.shtml",
    "datetime": "2021-04-13 09:56:29",
    "code": "002773"
  },
  {
    "title": "康弘药业(002773.SZ)：停止康柏西普眼用注射液全球多中心临床试验",
    "href": "http://stock.jrj.com.cn/2021/04/09221732344909.shtml",
    "datetime": "2021-04-09 22:17:23",
    "code": "002773"
  },
  {
    "title": "康弘药业：公司计划于2021年在中国和美国同时提交临床试验申请",
    "href": "http://stock.jrj.com.cn/2021/04/02170932271086.shtml",
    "datetime": "2021-04-02 17:09:46",
    "code": "002773"
  },
  {
    "title": "康弘药业：公司发行可转债募集的资金投入了KH系列生物新药产业化建设项目等4个募投项目",
    "href": "http://stock.jrj.com.cn/2021/04/02150332270335.shtml",
    "datetime": "2021-04-02 15:03:16",
    "code": "002773"
  },
  {
    "title": "【龙虎榜】康弘药业3月31日成交明细",
    "href": "http://stock.jrj.com.cn/hotstock/2021/03/31180032257141.shtml",
    "datetime": "2021-03-31 18:00:33",
    "code": "002773"
  },
  {
    "title": "康弘药业近三日累跌超20% 四机构合计卖出1.62亿元",
    "href": "http://stock.jrj.com.cn/2021/03/31163232256417.shtml",
    "datetime": "2021-03-31 16:32:12",
    "code": "002773"
  },
  {
    "title": "【龙虎榜】康弘药业3月30日成交明细",
    "href": "http://stock.jrj.com.cn/hotstock/2021/03/30180132248805.shtml",
    "datetime": "2021-03-30 18:01:32",
    "code": "002773"
  },
  {
    "title": "A股异动丨康弘药业(002773.SZ)再度触及跌停 当家产品海外临床试验被暂停",
    "href": "http://stock.jrj.com.cn/2021/03/30111332246889.shtml",
    "datetime": "2021-03-30 11:13:03",
    "code": "002773"
  },
  {
    "title": "【龙虎榜】康弘药业3月29日成交明细",
    "href": "http://stock.jrj.com.cn/hotstock/2021/03/29180032242265.shtml",
    "datetime": "2021-03-29 18:00:50",
    "code": "002773"
  },
  {
    "title": "康弘药业跌停 浙商证券本月最高点喊买入",
    "href": "http://stock.jrj.com.cn/2021/03/29164832241733.shtml",
    "datetime": "2021-03-29 16:48:00",
    "code": "002773"
  },
  {
    "title": "A股异动 | 康弘药业(002773.SZ)跌停 KHB-1802临床试验在法国暂停",
    "href": "http://stock.jrj.com.cn/2021/03/29101732239160.shtml",
    "datetime": "2021-03-29 10:17:17",
    "code": "002773"
  },
  {
    "title": "康弘药业(002773.SZ)：KHB-1802的相关临床试验在法国被暂停",
    "href": "http://stock.jrj.com.cn/2021/03/28203432231222.shtml",
    "datetime": "2021-03-28 20:34:37",
    "code": "002773"
  },
  {
    "title": "康弘药业董秘钟建军收监管函 窗口期288万买自家股票",
    "href": "http://stock.jrj.com.cn/2021/03/02174032058343.shtml",
    "datetime": "2021-03-02 17:40:00",
    "code": "002773"
  },
  {
    "title": "康弘药业2020年度净利8.39亿增长16.79% 主营业务保持稳定",
    "href": "http://stock.jrj.com.cn/2021/02/26223532035857.shtml",
    "datetime": "2021-02-26 22:35:10",
    "code": "002773"
  },
  {
    "title": "康弘药业(002773.SZ)业绩快报：2020年度净利润升16.79%至8.39亿元",
    "href": "http://stock.jrj.com.cn/2021/02/26194032034794.shtml",
    "datetime": "2021-02-26 19:40:45",
    "code": "002773"
  },
  {
    "title": "康弘药业：2020年前三季度公司研发投入（含费用化和资本化）较去年同期增长",
    "href": "http://stock.jrj.com.cn/2021/02/26155532033066.shtml",
    "datetime": "2021-02-26 15:55:15",
    "code": "002773"
  },
  {
    "title": "康弘药业(002773.SZ)：财务总监钟建军已增持25.06万股",
    "href": "http://stock.jrj.com.cn/2021/02/21173531999435.shtml",
    "datetime": "2021-02-21 17:35:45",
    "code": "002773"
  },
  {
    "title": "康弘药业(002773.SZ)：财务总监、董秘钟建军拟增持不低于50万股",
    "href": "http://stock.jrj.com.cn/2021/02/05193231855982.shtml",
    "datetime": "2021-02-05 19:32:28",
    "code": "002773"
  },
  {
    "title": "康弘药业：枸橼酸莫沙必利片（5mg）拟中标药品集采 有利于扩大相关产品销售规模",
    "href": "http://stock.jrj.com.cn/2021/02/04141232008712.shtml",
    "datetime": "2021-02-04 14:12:39",
    "code": "002773"
  },
  {
    "title": "康弘药业：枸橼酸莫沙必利片（5mg）拟中标药品集采 有利于扩大相关产品销售规模",
    "href": "http://stock.jrj.com.cn/2021/02/04141231848497.shtml",
    "datetime": "2021-02-04 14:12:39",
    "code": "002773"
  },
  {
    "title": "康弘药业(002773.SZ)：枸橼酸莫沙必利片中标第四批全国药品集采",
    "href": "http://stock.jrj.com.cn/2021/02/04115431847900.shtml",
    "datetime": "2021-02-04 11:54:29",
    "code": "002773"
  },
  {
    "title": "康弘药业(002773.SZ)：非公开发行股票申请获中证监受理",
    "href": "http://stock.jrj.com.cn/2020/12/30202931606685.shtml",
    "datetime": "2020-12-30 20:29:59",
    "code": "002773"
  },
  {
    "title": "康弘药业(002773.SZ)：枸橼酸莫沙必利片获得药品补充申请批准通知书",
    "href": "http://stock.jrj.com.cn/2020/12/18203431520751.shtml",
    "datetime": "2020-12-18 20:34:16",
    "code": "002773"
  },
  {
    "title": "康弘药业：本次发行目前尚未确定发行对象",
    "href": "http://stock.jrj.com.cn/2020/12/09131831448146.shtml",
    "datetime": "2020-12-09 13:18:46",
    "code": "002773"
  },
  {
    "title": "康弘药业拟定增募资不超34.72亿元",
    "href": "http://stock.jrj.com.cn/2020/12/04203731410535.shtml",
    "datetime": "2020-12-04 20:37:29",
    "code": "002773"
  },
  {
    "title": "康弘药业(002773.SZ)：部分募投项目结项并将5189.11万元永久补充流动资金",
    "href": "http://stock.jrj.com.cn/2020/12/04202231410460.shtml",
    "datetime": "2020-12-04 20:22:36",
    "code": "002773"
  },
  {
    "title": "康弘药业(002773.SZ)拟定增募资不超34.72亿元 用于康柏西普眼用注射液国际III期临床试验及注册上市项目等",
    "href": "http://stock.jrj.com.cn/2020/12/04201831410444.shtml",
    "datetime": "2020-12-04 20:18:12",
    "code": "002773"
  },
  {
    "title": "康弘药业：董事长柯尊洪累计减持1757.34万股 减持计划已实施完毕",
    "href": "http://stock.jrj.com.cn/2020/11/08174031237207.shtml",
    "datetime": "2020-11-08 17:40:36",
    "code": "002773"
  },
  {
    "title": "康弘药业(002773.SZ)：董事长已以大宗交易累计减持2%的股份",
    "href": "http://stock.jrj.com.cn/2020/11/08171331237176.shtml",
    "datetime": "2020-11-08 17:13:23",
    "code": "002773"
  },
  {
    "title": "康弘药业2020年前三季度净利5.79亿增长4.85% 政府补助增加",
    "href": "http://stock.jrj.com.cn/2020/10/27093231139992.shtml",
    "datetime": "2020-10-27 09:32:57",
    "code": "002773"
  },
  {
    "title": "康弘药业(002773.SZ)涨超4% 子公司通过FDA康柏西普玻璃体腔眼用注射液在美开展临床试验特别方案评审",
    "href": "http://stock.jrj.com.cn/2020/10/26142231133618.shtml",
    "datetime": "2020-10-26 14:22:47",
    "code": "002773"
  },
  {
    "title": "康弘药业(002773.SZ)：子公司通过FDA康柏西普玻璃体腔眼用注射液在美开展临床试验特别方案评审",
    "href": "http://stock.jrj.com.cn/2020/10/26085131131193.shtml",
    "datetime": "2020-10-26 08:51:35",
    "code": "002773"
  },
  {
    "title": "康弘药业(002773.SZ)：康柏西普眼用注射液临试项目进展顺利",
    "href": "http://stock.jrj.com.cn/2020/09/30131330866642.shtml",
    "datetime": "2020-09-30 13:13:18",
    "code": "002773"
  },
  {
    "title": "康弘药业：业绩小幅下滑 仍受机构青睐",
    "href": "http://stock.jrj.com.cn/2020/08/28004130607946.shtml",
    "datetime": "2020-08-28 00:41:18",
    "code": "002773"
  },
  {
    "title": "康弘药业2020年上半年净利3.35亿下滑1.68% 营业收入同比下滑",
    "href": "http://stock.jrj.com.cn/2020/08/26113130592428.shtml",
    "datetime": "2020-08-26 11:31:40",
    "code": "002773"
  },
  {
    "title": "[康弘药业]康柏西普眼用注射液在蒙古国获批上市",
    "href": "http://stock.jrj.com.cn/2020/07/01000030111987.shtml",
    "datetime": "2020-07-01 00:00:00",
    "code": "002773"
  },
  {
    "title": "快讯：康弘药业急速拉升6.92% 主力资金净流出84.74万元(dev)",
    "href": "http://stock.jrj.com.cn/2020/06/30095630094423.shtml",
    "datetime": "2020-06-30 09:56:11",
    "code": "002773"
  },
  {
    "title": "近一周机构调研个股数量超130只 机构扎堆康弘药业",
    "href": "http://stock.jrj.com.cn/hotstock/2020/06/15074829923490.shtml",
    "datetime": "2020-06-15 07:48:54",
    "code": "002773"
  },
  {
    "title": "康弘药业：子公司拟6000万元购买理财产品 可提高公司闲置资金使用效率",
    "href": "http://stock.jrj.com.cn/2020/06/09144029880625.shtml",
    "datetime": "2020-06-09 14:40:25",
    "code": "002773"
  },
  {
    "title": "康弘药业2019年净利7.18亿 增长3.35% 董事长柯尊洪薪酬132万",
    "href": "http://stock.jrj.com.cn/2020/05/03150229498004.shtml",
    "datetime": "2020-05-03 15:02:10",
    "code": "002773"
  },
  {
    "title": "康弘药业2020年第一季度盈利1.77亿元 下降16.30% 投资收益减少",
    "href": "http://stock.jrj.com.cn/2020/05/03143329497490.shtml",
    "datetime": "2020-05-03 14:33:39",
    "code": "002773"
  },
  {
    "title": "康弘药业股东殷劲群减持14万股 套现约560万元",
    "href": "http://stock.jrj.com.cn/2020/03/29214829136890.shtml",
    "datetime": "2020-03-29 21:48:24",
    "code": "002773"
  },
  {
    "title": "[康弘药业]成都市副市长牛清报一行莅临康弘药业调研",
    "href": "http://stock.jrj.com.cn/2020/03/12000030010734.shtml",
    "datetime": "2020-03-12 00:00:00",
    "code": "002773"
  },
  {
    "title": "康弘药业可转债中签号码出炉 共超128万个",
    "href": "http://stock.jrj.com.cn/2020/03/08161628973850.shtml",
    "datetime": "2020-03-08 16:16:00",
    "code": "002773"
  },
  {
    "title": "康弘药业：累计捐赠现金和物资超过700万元",
    "href": "http://stock.jrj.com.cn/2020/03/06171228968746.shtml",
    "datetime": "2020-03-06 17:12:00",
    "code": "002773"
  },
  {
    "title": "康弘药业：驰援超700万元 再捐赠10000套防护服",
    "href": "http://stock.jrj.com.cn/2020/03/06141828967473.shtml",
    "datetime": "2020-03-06 14:18:57",
    "code": "002773"
  },
  {
    "title": "康弘药业：驰援超700万 再捐赠10000套防护服",
    "href": "http://stock.jrj.com.cn/2020/03/06110428966354.shtml",
    "datetime": "2020-03-06 11:04:00",
    "code": "002773"
  },
  {
    "title": "康弘药业、正元智慧：康弘转债、正元转债网上中签率出炉",
    "href": "http://stock.jrj.com.cn/2020/03/05201428961127.shtml",
    "datetime": "2020-03-05 20:14:14",
    "code": "002773"
  },
  {
    "title": "康弘药业2019年净利7.18亿元增长3% 生物药经营业绩增长所致",
    "href": "http://stock.jrj.com.cn/2020/02/27233628909525.shtml",
    "datetime": "2020-02-27 23:36:56",
    "code": "002773"
  },
  {
    "title": "[康弘药业]金牛区区长周德强一行莅临康弘药业检查指导复工情况",
    "href": "http://stock.jrj.com.cn/2020/02/20000030010736.shtml",
    "datetime": "2020-02-20 00:00:00",
    "code": "002773"
  },
  {
    "title": "[康弘药业]变革创新 砥砺奋进——康弘药业2019年度总结大会暨2020新春联欢会隆重举行",
    "href": "http://stock.jrj.com.cn/2020/01/20000030010733.shtml",
    "datetime": "2020-01-20 00:00:00",
    "code": "002773"
  },
  {
    "title": "康弘药业：2019年年度业绩报告预告",
    "href": "http://stock.jrj.com.cn/2020/01/15011028677747.shtml",
    "datetime": "2020-01-15 01:10:00",
    "code": "002773"
  },
  {
    "title": "康弘药业预计2019年盈利6.95亿元至7.64亿元 同比增长0%至10%",
    "href": "http://stock.jrj.com.cn/2020/01/14215328677290.shtml",
    "datetime": "2020-01-14 21:53:52",
    "code": "002773"
  },
  {
    "title": "康弘药业使用不超过17亿元闲置资金购买理财产品",
    "href": "http://stock.jrj.com.cn/2020/01/11172228662411.shtml",
    "datetime": "2020-01-11 17:22:26",
    "code": "002773"
  },
  {
    "title": "康弘药业公开发行可转债申请获证监会核准批复",
    "href": "http://stock.jrj.com.cn/2020/01/02214928619545.shtml",
    "datetime": "2020-01-02 21:49:00",
    "code": "002773"
  },
  {
    "title": "康弘药业：获准公开发行16.3亿元可转债",
    "href": "http://stock.jrj.com.cn/2020/01/02202828619222.shtml",
    "datetime": "2020-01-02 20:28:07",
    "code": "002773"
  },
  {
    "title": "康弘药业公开发行16.3亿元可转债申请获核准",
    "href": "http://stock.jrj.com.cn/2020/01/02202728619216.shtml",
    "datetime": "2020-01-02 20:27:01",
    "code": "002773"
  },
  {
    "title": "康弘药业：公开发行16.3亿元可转债申请获核准",
    "href": "http://stock.jrj.com.cn/2020/01/02201028619168.shtml",
    "datetime": "2020-01-02 20:10:00",
    "code": "002773"
  },
  {
    "title": "康弘药业：子公司康柏西普眼用注射液临床试验项目进展顺利",
    "href": "http://stock.jrj.com.cn/2019/12/24211028580986.shtml",
    "datetime": "2019-12-24 21:10:20",
    "code": "002773"
  },
  {
    "title": "康弘药业：康柏西普眼用注射液临床试验项目进展顺利",
    "href": "http://stock.jrj.com.cn/2019/12/24204328580946.shtml",
    "datetime": "2019-12-24 20:43:00",
    "code": "002773"
  },
  {
    "title": "康弘药业：子公司获得药品补充申请批件",
    "href": "http://stock.jrj.com.cn/2019/12/24201728580870.shtml",
    "datetime": "2019-12-24 20:17:06",
    "code": "002773"
  },
  {
    "title": "康弘药业股东殷劲群拟减持股份 预计减持不超总股本0.02%",
    "href": "http://stock.jrj.com.cn/2019/12/20230028564944.shtml",
    "datetime": "2019-12-20 23:00:15",
    "code": "002773"
  },
  {
    "title": "康弘药业：有中药产品往阿尔兹海默症方向在展开 已进入临床阶段",
    "href": "http://stock.jrj.com.cn/2019/12/19151328557274.shtml",
    "datetime": "2019-12-19 15:13:00",
    "code": "002773"
  },
  {
    "title": "康弘药业：加快推进国际化步伐",
    "href": "http://stock.jrj.com.cn/2019/12/19150528557272.shtml",
    "datetime": "2019-12-19 15:05:00",
    "code": "002773"
  },
  {
    "title": "康弘药业：研发费用占比会越来越大",
    "href": "http://stock.jrj.com.cn/2019/12/19150228557278.shtml",
    "datetime": "2019-12-19 15:02:00",
    "code": "002773"
  },
  {
    "title": "康弘药业：康柏西普眼用注射液的上市打破了国际垄断",
    "href": "http://stock.jrj.com.cn/2019/12/19145828557275.shtml",
    "datetime": "2019-12-19 14:58:00",
    "code": "002773"
  },
  {
    "title": "康弘药业股价涨超20% 核心药品“续签”国药目录助业绩重回高增长？",
    "href": "http://stock.jrj.com.cn/2019/12/03085328523560.shtml",
    "datetime": "2019-12-03 08:53:00",
    "code": "002773"
  },
  {
    "title": "康弘药业股价涨超20% 核心药品“续签”国药目录助业绩重回高增长？",
    "href": "http://stock.jrj.com.cn/2019/12/03085328481553.shtml",
    "datetime": "2019-12-03 08:53:00",
    "code": "002773"
  },
  {
    "title": "康弘药业股价涨超20% 核心药品“续签”国药目录助业绩重回高增长？",
    "href": "http://stock.jrj.com.cn/2019/12/03085328492624.shtml",
    "datetime": "2019-12-03 08:53:00",
    "code": "002773"
  },
  {
    "title": "[康弘药业]康弘药业松龄血脉康胶囊荣获“2019年度临床价值中成药品牌”奖",
    "href": "http://stock.jrj.com.cn/2019/12/03000030010732.shtml",
    "datetime": "2019-12-03 00:00:00",
    "code": "002773"
  },
  {
    "title": "数据复盘｜主力大举加仓格力电器等5股 机构抢筹康弘药业",
    "href": "http://stock.jrj.com.cn/invest/2019/11/28183928464541.shtml",
    "datetime": "2019-11-28 18:39:00",
    "code": "002773"
  },
  {
    "title": "康弘药业：公司康柏西普眼用注射液纳入国家医保目录",
    "href": "http://stock.jrj.com.cn/2019/11/28180728464124.shtml",
    "datetime": "2019-11-28 18:07:28",
    "code": "002773"
  },
  {
    "title": "康弘药业：康柏西普眼用注射液被纳入国家医保目录",
    "href": "http://stock.jrj.com.cn/2019/11/28175628464098.shtml",
    "datetime": "2019-11-28 17:56:31",
    "code": "002773"
  },
  {
    "title": "部分医药股盘中拉升 康弘药业涨停",
    "href": "http://stock.jrj.com.cn/2019/11/28111628462628.shtml",
    "datetime": "2019-11-28 11:16:00",
    "code": "002773"
  },
  {
    "title": "[康弘药业]康弘药业荣获“最具成长性大健康产业上市公司”称号",
    "href": "http://stock.jrj.com.cn/2019/11/18000030010730.shtml",
    "datetime": "2019-11-18 00:00:00",
    "code": "002773"
  },
  {
    "title": "医药板块小幅走高 赛升药业康弘药业涨停",
    "href": "http://stock.jrj.com.cn/hotstock/2019/11/14141128398870.shtml",
    "datetime": "2019-11-14 14:11:00",
    "code": "002773"
  },
  {
    "title": "[康弘药业]康弘药业荣获“2018年度金牛最具投资价值奖”",
    "href": "http://stock.jrj.com.cn/2019/11/04000030010729.shtml",
    "datetime": "2019-11-04 00:00:00",
    "code": "002773"
  },
  {
    "title": "康弘药业：盐酸文拉法辛缓释片通过一致性评价",
    "href": "http://stock.jrj.com.cn/2019/11/01205328340825.shtml",
    "datetime": "2019-11-01 20:53:21",
    "code": "002773"
  },
  {
    "title": "康弘药业：产品通过仿制药质量和疗效一致性评价",
    "href": "http://stock.jrj.com.cn/2019/11/01200328340602.shtml",
    "datetime": "2019-11-01 20:03:20",
    "code": "002773"
  },
  {
    "title": "康弘药业第三季度盈利2.1亿 同比增长8%",
    "href": "http://stock.jrj.com.cn/2019/10/31132628332839.shtml",
    "datetime": "2019-10-31 13:26:06",
    "code": "002773"
  },
  {
    "title": "康弘药业使用自有资金购买5000万理财产品",
    "href": "http://stock.jrj.com.cn/2019/09/29172628196931.shtml",
    "datetime": "2019-09-29 17:26:48",
    "code": "002773"
  },
  {
    "title": "康弘药业股东钟建军减持297万股 套现约9915万元",
    "href": "http://stock.jrj.com.cn/2019/09/19143128153400.shtml",
    "datetime": "2019-09-19 14:31:08",
    "code": "002773"
  },
  {
    "title": "康弘药业董秘到底欠了多少债？套现5300万以偿还个人债务和满足资金需求",
    "href": "http://stock.jrj.com.cn/2019/08/28141728048954.shtml",
    "datetime": "2019-08-28 14:17:13",
    "code": "002773"
  },
  {
    "title": "康弘药业股东钟建军拟减持股份 预计减持不超总股本0.34%",
    "href": "http://stock.jrj.com.cn/2019/08/28101628047534.shtml",
    "datetime": "2019-08-28 10:16:45",
    "code": "002773"
  },
  {
    "title": "康弘药业2019年上半年净利3.4亿 企业持续良性发展",
    "href": "http://stock.jrj.com.cn/2019/08/25175228028755.shtml",
    "datetime": "2019-08-25 17:52:38",
    "code": "002773"
  },
  {
    "title": "不差钱的康弘药业缘何发可转债",
    "href": "http://stock.jrj.com.cn/2019/07/27135527894380.shtml",
    "datetime": "2019-07-27 13:55:19",
    "code": "002773"
  },
  {
    "title": "康弘药业获国内首个阿立哌唑口服溶液生产批件",
    "href": "http://stock.jrj.com.cn/2019/07/16191127848657.shtml",
    "datetime": "2019-07-16 19:11:38",
    "code": "002773"
  },
  {
    "title": "康弘药业：获国内首个阿立哌唑口服溶液生产批件",
    "href": "http://stock.jrj.com.cn/2019/07/16185927848633.shtml",
    "datetime": "2019-07-16 18:59:00",
    "code": "002773"
  },
  {
    "title": "康弘药业：关于2015年限制性股票激励计划预留部分第二个解锁期解锁限制性股票上市流通的提示性公告",
    "href": "http://stock.jrj.com.cn/2019/07/09214027818267.shtml",
    "datetime": "2019-07-09 21:40:00",
    "code": "002773"
  },
  {
    "title": "鼎晖系减持康弘药业部分股权",
    "href": "http://stock.jrj.com.cn/2019/07/09122627816073.shtml",
    "datetime": "2019-07-09 12:26:43",
    "code": "002773"
  },
  {
    "title": "午间公告：康弘药业股东鼎晖维鑫等减持1.10%股份",
    "href": "http://stock.jrj.com.cn/2019/07/09122027816045.shtml",
    "datetime": "2019-07-09 12:20:09",
    "code": "002773"
  },
  {
    "title": "午间公告：康弘药业股东鼎晖维鑫等减持1.10%股份",
    "href": "http://stock.jrj.com.cn/2019/07/09120427816036.shtml",
    "datetime": "2019-07-09 12:04:00",
    "code": "002773"
  },
  {
    "title": "康弘药业财务总监钟建军拟减持股份 预计减持不超总股本0.34%",
    "href": "http://stock.jrj.com.cn/2019/07/02073427784062.shtml",
    "datetime": "2019-07-02 07:34:13",
    "code": "002773"
  },
  {
    "title": "[康弘药业]康弘药业二〇一八年度报告网上说明会顺利举办",
    "href": "http://stock.jrj.com.cn/2019/05/20000027595329.shtml",
    "datetime": "2019-05-20 00:00:00",
    "code": "002773"
  },
  {
    "title": "康弘药业“康柏西普”第三个适应症获批",
    "href": "http://stock.jrj.com.cn/2019/05/17220227587918.shtml",
    "datetime": "2019-05-17 22:02:16",
    "code": "002773"
  },
  {
    "title": "康弘药业：康柏西普眼用注射液获得药品注册批件",
    "href": "http://stock.jrj.com.cn/2019/05/16214227583053.shtml",
    "datetime": "2019-05-16 21:42:36",
    "code": "002773"
  },
  {
    "title": "康弘药业：康柏西普眼用注射液获药品注册批件",
    "href": "http://stock.jrj.com.cn/2019/05/16200627582775.shtml",
    "datetime": "2019-05-16 20:06:00",
    "code": "002773"
  },
  {
    "title": "康弘药业：收到康柏西普眼用注射液的临床试验通知书",
    "href": "http://stock.jrj.com.cn/2019/05/07181427538333.shtml",
    "datetime": "2019-05-07 18:14:00",
    "code": "002773"
  },
  {
    "title": "康弘药业一季度净利2.11亿元 现金流量净额为7621万元",
    "href": "http://stock.jrj.com.cn/2019/05/06073327526963.shtml",
    "datetime": "2019-05-06 07:33:56",
    "code": "002773"
  },
  {
    "title": "康弘药业：2018年净利6.95亿元 同比增长7.88%",
    "href": "http://stock.jrj.com.cn/2019/04/28213927502946.shtml",
    "datetime": "2019-04-28 21:39:30",
    "code": "002773"
  },
  {
    "title": "康弘药业：拟发行可转债募资不超16.3亿元",
    "href": "http://stock.jrj.com.cn/2019/04/28213527502930.shtml",
    "datetime": "2019-04-28 21:35:50",
    "code": "002773"
  },
  {
    "title": "康弘药业：2018年净利6.95亿元 拟10转3派2.8元",
    "href": "http://stock.jrj.com.cn/2019/04/28201727502764.shtml",
    "datetime": "2019-04-28 20:17:49",
    "code": "002773"
  },
  {
    "title": "康弘药业：2018年实现净利润6.95亿元 同比增长7.88%",
    "href": "http://stock.jrj.com.cn/2019/04/28200827502735.shtml",
    "datetime": "2019-04-28 20:08:28",
    "code": "002773"
  },
  {
    "title": "[康弘药业]四川省人民政府副省长王一宏一行莅临康弘药业调研",
    "href": "http://stock.jrj.com.cn/2019/04/23000027465404.shtml",
    "datetime": "2019-04-23 00:00:00",
    "code": "002773"
  },
  {
    "title": "[康弘药业]康弘国际生产及研发中心建设项目奠基仪式圆满举行",
    "href": "http://stock.jrj.com.cn/2019/03/29000027267617.shtml",
    "datetime": "2019-03-29 00:00:00",
    "code": "002773"
  },
  {
    "title": "康弘药业：依匹哌唑口崩片获得批临床试验",
    "href": "http://stock.jrj.com.cn/2019/03/12201727155433.shtml",
    "datetime": "2019-03-12 20:17:09",
    "code": "002773"
  },
  {
    "title": "康弘药业：依匹哌唑口崩片获批临床试验",
    "href": "http://stock.jrj.com.cn/2019/03/12184727155202.shtml",
    "datetime": "2019-03-12 18:47:00",
    "code": "002773"
  },
  {
    "title": "成都药企的创新发展样本：康弘药业打破外资药品的市场垄断",
    "href": "http://stock.jrj.com.cn/2019/02/13193027039478.shtml",
    "datetime": "2019-02-13 19:30:58",
    "code": "002773"
  },
  {
    "title": "康弘药业副总裁赵兴平减持106万股 套现约4000万元",
    "href": "http://stock.jrj.com.cn/2019/02/11221527029649.shtml",
    "datetime": "2019-02-11 22:15:51",
    "code": "002773"
  },
  {
    "title": "[康弘药业]迎接新挑战 续写新辉煌——康弘药业2018年度总结大会暨2019新春联欢会隆重举行",
    "href": "http://stock.jrj.com.cn/2019/02/01000027013986.shtml",
    "datetime": "2019-02-01 00:00:00",
    "code": "002773"
  },
  {
    "title": "[康弘药业]康弘药业开展2019年残疾员工新春慰问活动",
    "href": "http://stock.jrj.com.cn/2019/01/21000026935792.shtml",
    "datetime": "2019-01-21 00:00:00",
    "code": "002773"
  },
  {
    "title": "[康弘药业]四川省药监局局长张大中一行莅临康弘药业调研",
    "href": "http://stock.jrj.com.cn/2019/01/08000026874437.shtml",
    "datetime": "2019-01-08 00:00:00",
    "code": "002773"
  },
  {
    "title": "[康弘药业]康弘“公司开放日”隆重举行",
    "href": "http://stock.jrj.com.cn/2019/01/02000026935791.shtml",
    "datetime": "2019-01-02 00:00:00",
    "code": "002773"
  },
  {
    "title": "康弘药业：阿立哌唑口崩片获得药品补充申请批件",
    "href": "http://stock.jrj.com.cn/hotstock/2018/12/27080026809776.shtml",
    "datetime": "2018-12-27 08:00:01",
    "code": "002773"
  },
  {
    "title": "[康弘药业]成都康弘制药有限公司荣获“双流区优秀民营企业”称号",
    "href": "http://stock.jrj.com.cn/2018/12/21000026791556.shtml",
    "datetime": "2018-12-21 00:00:00",
    "code": "002773"
  },
  {
    "title": "医药板块结束三连跌 券商力荐7只超跌高成长股",
    "href": "http://stock.jrj.com.cn/2018/12/12005025590527.shtml",
    "datetime": "2018-12-12 00:50:17",
    "code": "002773"
  },
  {
    "title": "[康弘药业]康柏西普眼用注射液荣获中国工业大奖",
    "href": "http://stock.jrj.com.cn/2018/12/10000025499391.shtml",
    "datetime": "2018-12-10 00:00:00",
    "code": "002773"
  },
  {
    "title": "[康弘药业]康弘药业荣获“四川省优秀民营企业”称号",
    "href": "http://stock.jrj.com.cn/2018/11/22000025393071.shtml",
    "datetime": "2018-11-22 00:00:00",
    "code": "002773"
  },
  {
    "title": "[康弘药业]康弘药业荣获“2018中国上市公司口碑榜”两项大奖",
    "href": "http://stock.jrj.com.cn/2018/11/20000025380536.shtml",
    "datetime": "2018-11-20 00:00:00",
    "code": "002773"
  },
  {
    "title": "[康弘药业]康弘药业获得“第20届中国上市公司金牛奖 ”两项荣誉",
    "href": "http://stock.jrj.com.cn/2018/11/20000025380537.shtml",
    "datetime": "2018-11-20 00:00:00",
    "code": "002773"
  },
  {
    "title": "鼎晖投出上市公司康弘药业：7年7倍收益 股价低迷套现犹如龟速",
    "href": "http://stock.jrj.com.cn/2018/11/13135225339175.shtml",
    "datetime": "2018-11-13 13:52:00",
    "code": "002773"
  },
  {
    "title": "[康弘药业]“朗视界 沐光明”大型慈善义诊活动走进汶川",
    "href": "http://stock.jrj.com.cn/2018/11/08000025319765.shtml",
    "datetime": "2018-11-08 00:00:00",
    "code": "002773"
  },
  {
    "title": "康弘药业：子公司获得药物临床试验批件",
    "href": "http://stock.jrj.com.cn/2018/11/07184725315738.shtml",
    "datetime": "2018-11-07 18:47:00",
    "code": "002773"
  },
  {
    "title": "康弘药业：五加益智颗粒获得药物临床试验批件",
    "href": "http://stock.jrj.com.cn/2018/11/07181825315536.shtml",
    "datetime": "2018-11-07 18:18:29",
    "code": "002773"
  },
  {
    "title": "[康弘药业]成都市经信委党组书记、主任陈志勇一行莅临康弘药业调研",
    "href": "http://stock.jrj.com.cn/2018/10/26000025263430.shtml",
    "datetime": "2018-10-26 00:00:00",
    "code": "002773"
  },
  {
    "title": "康弘药业：2018年年度业绩报告预告",
    "href": "http://stock.jrj.com.cn/2018/10/22214025239578.shtml",
    "datetime": "2018-10-22 21:40:00",
    "code": "002773"
  },
  {
    "title": "康弘药业：2018年度净利预增5%至35%",
    "href": "http://stock.jrj.com.cn/2018/10/22202525240584.shtml",
    "datetime": "2018-10-22 20:25:00",
    "code": "002773"
  },
  {
    "title": "[康弘药业]助力中国药学事业发展 康弘药业向“米玉士教育发展基金”捐赠450万元",
    "href": "http://stock.jrj.com.cn/2018/09/30000025167067.shtml",
    "datetime": "2018-09-30 00:00:00",
    "code": "002773"
  },
  {
    "title": "[康弘药业]“大爱康弘·情系美姑”康弘药业深入美姑县采红乡石拖村举行精准扶贫启动仪式",
    "href": "http://stock.jrj.com.cn/2018/09/28000025150545.shtml",
    "datetime": "2018-09-28 00:00:00",
    "code": "002773"
  },
  {
    "title": "[康弘药业]康弘药业受邀参加2018第五届诺贝尔奖获得者医学峰会",
    "href": "http://stock.jrj.com.cn/2018/09/13000025086778.shtml",
    "datetime": "2018-09-13 00:00:00",
    "code": "002773"
  },
  {
    "title": "[康弘药业]柯尊洪董事长荣获“纪念改革开放40年医药产业功勋人物”称号",
    "href": "http://stock.jrj.com.cn/2018/09/12000025082815.shtml",
    "datetime": "2018-09-12 00:00:00",
    "code": "002773"
  },
  {
    "title": "[康弘药业]康弘药业获得“2018中国医药上市公司竞争力20强”等三项荣誉",
    "href": "http://stock.jrj.com.cn/2018/09/07000025067289.shtml",
    "datetime": "2018-09-07 00:00:00",
    "code": "002773"
  },
  {
    "title": "康弘药业：康柏西普增速靓丽，传统板块拖累业绩",
    "href": "http://stock.jrj.com.cn/2018/09/05134525050138.shtml",
    "datetime": "2018-09-05 13:45:00",
    "code": "002773"
  },
  {
    "title": "[康弘药业]康弘药业独立董事及监事现场走访公司募投项目",
    "href": "http://stock.jrj.com.cn/2018/08/31000025050457.shtml",
    "datetime": "2018-08-31 00:00:00",
    "code": "002773"
  },
  {
    "title": "[康弘药业]成都市人大常委会副主任王忠林一行莅临康弘药业调研",
    "href": "http://stock.jrj.com.cn/2018/08/29000025025146.shtml",
    "datetime": "2018-08-29 00:00:00",
    "code": "002773"
  },
  {
    "title": "康弘药业：2018年前三季度业绩报告预告",
    "href": "http://stock.jrj.com.cn/2018/08/28225025016168.shtml",
    "datetime": "2018-08-28 22:50:00",
    "code": "002773"
  },
  {
    "title": "每经专访康弘药业董事长柯尊洪：医药行业的创新得益于改革开放",
    "href": "http://stock.jrj.com.cn/2018/08/16185724962828.shtml",
    "datetime": "2018-08-16 18:57:33",
    "code": "002773"
  },
  {
    "title": "[康弘药业]康弘药业荣登工信部“2017年度中国医药工业百强企业”榜单",
    "href": "http://stock.jrj.com.cn/2018/08/08000024925594.shtml",
    "datetime": "2018-08-08 00:00:00",
    "code": "002773"
  },
  {
    "title": "[康弘药业]成都市政协副主席杨建德一行莅临康弘药业调研",
    "href": "http://stock.jrj.com.cn/2018/08/07000024923389.shtml",
    "datetime": "2018-08-07 00:00:00",
    "code": "002773"
  },
  {
    "title": "[康弘药业]首届“医卫界 济众生”大型精神卫生系列义诊活动圆满收官",
    "href": "http://stock.jrj.com.cn/2018/08/07000024923393.shtml",
    "datetime": "2018-08-07 00:00:00",
    "code": "002773"
  },
  {
    "title": "[康弘药业]中央组织部组织一局三处调研员、副处长李迅一行莅临康弘药业专题调研",
    "href": "http://stock.jrj.com.cn/2018/07/24000024859778.shtml",
    "datetime": "2018-07-24 00:00:00",
    "code": "002773"
  },
  {
    "title": "康弘药业股东拟减持不超4.45%股份",
    "href": "http://stock.jrj.com.cn/2018/07/17194724829677.shtml",
    "datetime": "2018-07-17 19:47:14",
    "code": "002773"
  },
  {
    "title": "康弘药业：股东拟减持不超4.45%股份",
    "href": "http://stock.jrj.com.cn/2018/07/17191524829547.shtml",
    "datetime": "2018-07-17 19:15:00",
    "code": "002773"
  },
  {
    "title": "康弘药业：两高管同时宣布减持计划",
    "href": "http://stock.jrj.com.cn/2018/07/10194024796310.shtml",
    "datetime": "2018-07-10 19:40:20",
    "code": "002773"
  },
  {
    "title": "[康弘药业]中国医药质量管理协会调研组一行莅临康弘药业调研",
    "href": "http://stock.jrj.com.cn/2018/07/06000024828252.shtml",
    "datetime": "2018-07-06 00:00:00",
    "code": "002773"
  },
  {
    "title": "康弘药业发起人拟减持不超过51万股",
    "href": "http://stock.jrj.com.cn/2018/06/10171924659983.shtml",
    "datetime": "2018-06-10 17:19:00",
    "code": "002773"
  },
  {
    "title": "康弘药业：朗沐获得药品再注册批件",
    "href": "http://stock.jrj.com.cn/2018/06/01094024624562.shtml",
    "datetime": "2018-06-01 09:40:00",
    "code": "002773"
  },
  {
    "title": "康弘药业：子公司获药物临床试验批件",
    "href": "http://stock.jrj.com.cn/2018/05/28095424598098.shtml",
    "datetime": "2018-05-28 09:54:00",
    "code": "002773"
  },
  {
    "title": "康弘药业子公司获得药物临床试验批件",
    "href": "http://stock.jrj.com.cn/2018/05/27171324595441.shtml",
    "datetime": "2018-05-27 17:13:49",
    "code": "002773"
  },
  {
    "title": "康弘药业一季度盈利20599万元 同比增长36%",
    "href": "http://stock.jrj.com.cn/2018/04/27094824462758.shtml",
    "datetime": "2018-04-27 09:48:00",
    "code": "002773"
  },
  {
    "title": "康弘药业：2018年半年度业绩报告预告",
    "href": "http://stock.jrj.com.cn/2018/04/26213024458920.shtml",
    "datetime": "2018-04-26 21:30:00",
    "code": "002773"
  },
  {
    "title": "康弘药业：子公司通过美国FDA开展临床试验特别方案评审",
    "href": "http://stock.jrj.com.cn/2018/04/20134124422423.shtml",
    "datetime": "2018-04-20 13:41:00",
    "code": "002773"
  },
  {
    "title": "公司业务出现重大进展 康弘药业午后出现异动",
    "href": "http://stock.jrj.com.cn/2018/04/20131824422349.shtml",
    "datetime": "2018-04-20 13:18:52",
    "code": "002773"
  },
  {
    "title": "[康弘药业]中国民营经济研究会调研组一行莅临康弘药业调研",
    "href": "http://stock.jrj.com.cn/2018/03/20000024288083.shtml",
    "datetime": "2018-03-20 00:00:00",
    "code": "002773"
  },
  {
    "title": "[康弘药业]康弘药业荣获第十届健康中国总评榜两项大奖",
    "href": "http://stock.jrj.com.cn/2018/01/24000024105990.shtml",
    "datetime": "2018-01-24 00:00:00",
    "code": "002773"
  },
  {
    "title": "[康弘药业]康弘药业董事长柯尊洪荣获第十二届人民企业社会责任奖“年度人物奖”",
    "href": "http://stock.jrj.com.cn/2018/01/24000024105989.shtml",
    "datetime": "2018-01-24 00:00:00",
    "code": "002773"
  },
  {
    "title": "康弘药业：正研发眼科药物二代产品 家族持股比例高是董事长看好前景",
    "href": "http://stock.jrj.com.cn/2017/12/29155523872640.shtml",
    "datetime": "2017-12-29 15:55:00",
    "code": "002773"
  },
  {
    "title": "康弘药业：眼科为长期战略发展方向 正在研发二代产品",
    "href": "http://stock.jrj.com.cn/2017/12/08131023763223.shtml",
    "datetime": "2017-12-08 13:10:00",
    "code": "002773"
  },
  {
    "title": "康弘药业眼科布局与国际化战略双线齐发",
    "href": "http://stock.jrj.com.cn/2017/12/07054123753287.shtml",
    "datetime": "2017-12-07 05:41:49",
    "code": "002773"
  },
  {
    "title": "[康弘药业]康弘药业签订海外合作协议",
    "href": "http://stock.jrj.com.cn/2017/11/24000023697900.shtml",
    "datetime": "2017-11-24 00:00:00",
    "code": "002773"
  },
  {
    "title": "[康弘药业]国家药典委员会调研组一行莅临康弘药业调研",
    "href": "http://stock.jrj.com.cn/2017/11/24000023697901.shtml",
    "datetime": "2017-11-24 00:00:00",
    "code": "002773"
  },
  {
    "title": "[康弘药业]工业和信息化部副部长罗文一行莅临康弘药业调研",
    "href": "http://stock.jrj.com.cn/2017/09/03000023051888.shtml",
    "datetime": "2017-09-03 00:00:00",
    "code": "002773"
  },
  {
    "title": "康弘药业：2017年前三季度业绩报告预告",
    "href": "http://stock.jrj.com.cn/2017/08/22210022982825.shtml",
    "datetime": "2017-08-22 21:00:00",
    "code": "002773"
  },
  {
    "title": "康弘药业：子公司签署药品准入协议",
    "href": "http://stock.jrj.com.cn/hotstock/2017/07/20080022773405.shtml",
    "datetime": "2017-07-20 08:00:00",
    "code": "002773"
  },
  {
    "title": "康弘药业：上方30日均线有一定压力",
    "href": "http://stock.jrj.com.cn/2017/02/23192522601512.shtml",
    "datetime": "2017-02-23 19:25:00",
    "code": "002773"
  },
  {
    "title": "康弘药业：获得药物临床试验批件",
    "href": "http://stock.jrj.com.cn/2016/10/24064321606938.shtml",
    "datetime": "2016-10-24 06:43:01",
    "code": "002773"
  },
  {
    "title": "康弘药业获美国FDA准许开展III期临床试验",
    "href": "http://stock.jrj.com.cn/2016/10/10090821546339.shtml",
    "datetime": "2016-10-10 09:08:03",
    "code": "002773"
  },
  {
    "title": "康弘药业：获得药物临床试验批件 股价同步大势概率大",
    "href": "http://stock.jrj.com.cn/2016/06/02222121031641.shtml",
    "datetime": "2016-06-02 22:21:38",
    "code": "002773"
  },
  {
    "title": "康弘药业一药物获批临床试验",
    "href": "http://stock.jrj.com.cn/hotstock/2016/02/18034120571137.shtml",
    "datetime": "2016-02-18 03:41:07",
    "code": "002773"
  },
  {
    "title": "康弘药业推出460万股股票激励计划",
    "href": "http://stock.jrj.com.cn/2015/12/15094120240333.shtml",
    "datetime": "2015-12-15 09:41:36",
    "code": "002773"
  }
]